Deferred Tax Assets, Valuation Allowance of BioRestorative Therapies, Inc. from 31 Dec 2012 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
BioRestorative Therapies, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2012 to 31 Dec 2024.
  • BioRestorative Therapies, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $29,434,100, a 7.6% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

BioRestorative Therapies, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $29,434,100 -$2,405,900 -7.6% 31 Dec 2024 10-K 28 Mar 2025 2024 FY
Q4 2023 $31,840,000 +$4,064,000 +15% 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q4 2022 $27,776,000 +$5,822,000 +27% 31 Dec 2022 10-K/A 11 Jun 2024 2023 FY
Q4 2021 $21,954,000 +$7,856,000 +56% 31 Dec 2021 10-K 27 Mar 2023 2022 FY
Q4 2020 $14,098,000 +$2,086,000 +17% 31 Dec 2020 10-K 30 Mar 2022 2021 FY
Q4 2019 $12,012,000 +$3,834,000 +47% 31 Dec 2019 10-K 30 Apr 2021 2020 FY
Q4 2018 $8,178,000 +$2,790,000 +52% 31 Dec 2018 10-K 18 Mar 2021 2019 FY
Q4 2017 $5,388,000 -$1,291,000 -19% 31 Dec 2017 10-K 29 Mar 2019 2018 FY
Q4 2016 $6,679,000 +$3,271,520 +96% 31 Dec 2016 10-K 02 Apr 2018 2017 FY
Q4 2015 $3,407,480 -$2,922,620 -46% 31 Dec 2015 10-K 22 Mar 2017 2016 FY
Q4 2014 $6,330,100 -$43,500 -0.68% 31 Dec 2014 10-K 30 Mar 2016 2015 FY
Q4 2013 $6,373,600 +$1,631,300 +34% 31 Dec 2013 10-K 31 Mar 2015 2014 FY
Q4 2012 $4,742,300 31 Dec 2012 10-K 11 Apr 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.